Updated 20:04 GMT, 28 Oct 2026 SPX 7,744.01 +0.28% NDX 29,813.16 +0.55% VIX 16.87 -3.71% GOLD 4,077.30 +0.07% CL 102.52 +2.62% BTC 81,597.92 +0.98%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,077 +0.07% BTC $81,598 +0.98% VIX 16.87 −3.71% latest tape · as of 20:04 UTC
The Screen · Financials · Banks - Regional

TrustCo Bank Corp NY

TRST · Nasdaq · USD · Market cap $990M · 740 employees

TrustCo Bank Corp NY operates as the holding company for Trustco Bank that provides personal and business banking services to individuals and businesses.

FAIL · Does not pass the screen
55.73 USD

Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago

Screened 2026-10-23 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price55.73 USD at the 23 Oct 2026 close
  • Ethical screenDoes not pass
  • Last reviewed23 Oct 2026 (5 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
29.1231.8448.54

What this means: price 55.73 against the desk's fair-value range, base estimate 31.84, over the last year.

Current read
Markdown ?
Screened · screened 2026-10-23
  • Trend Markdown
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price55.73 USD
Fair value31.84
Ethical score30.0/100
Our investment reviews on this name
2026-10-02Read Markdown56.67-1.7% to today ✓Accumulation gives way to Markdown
2026-07-02Read Accumulation55.25+0.9% to today ✓First review on file: Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markdown label.

TrustCo Bank Corp NY holds its Markdown at $55.73. The statistical read favours the sellers, held for 16 days.

As held on the ledger · 2026-10-23
PhaseMarkdown · caution
Quantitative stateThe statistical read favours the sellers, held for 16 days
Price at the screen$55.73
Valuation16.62 trailing · 19.75 forward price to earnings
Values screenFAIL · score 30.0
Beta0.65
The Workings

Five Screens, Shown in Full

Does not pass. Prohibited keyword in sector/industry: bank

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Prohibited keyword in sector/industry: bank Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

TrustCo Bank Corp NY does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when TRST's ethical verdict changes

Today TRST does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

29.12Conservative31.84Base case48.54Growth case 55.73Price

Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. The price runs 40.9% above the base estimate.

Price History & Projections
$57.1$39.6$22.1TODAY5y agoPROJECTIONOur fair value$31.84 -42%Conservative$29.12 -47%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E19.8xexpensive even after accounting for its growth
Trailing P/E16.6xreasonably valued
EPS, trailing3.41
EPS, forward2.87
Revenue growth+7.9%slow but positive growth
Profit margin33.3%highly profitable on every dollar of sales
Return on equity9.3%a modest return on shareholder capital
Dividend yield275.00%
Beta0.65steadier than the market
Short interest, float0.05%
52-week range30.52 - 55.60
Market cap$990M
Employees740

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

TRST trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-28 Markdown $53.87 +0.0% Entry 16

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%.

2026-10-21 Markdown $53.87 +0.0% Entry 15

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-20 Markdown $53.87 +0.0% Entry 14

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-19 Markdown $53.87 +0.0% Entry 13

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-18 Markdown $53.87 +0.0% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-17 Markdown $53.87 +0.0% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-16 Markdown $53.87 +0.5% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-15 Markdown $53.59 +0.0% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-14 Markdown $53.59 +0.0% Entry 8

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-13 Markdown $53.59 -5.4% Entry 7

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 76%. Our forward projection puts the odds of a 10% gain over the next month near 28%. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $48.16 +13.6% $0.38 $1,143 +14.3%
2 months $46.09 +18.7% $0.38 $1,195 +19.5%
3 months $43.11 +26.9% $0.38 $1,278 +27.8%
6 months $44.14 +23.9% $0.76 $1,256 +25.6%
1 year $30.99 +76.5% $1.52 $1,814 +81.4%
2 years $24.47 +123.5% $2.96 $2,356 +135.6%
3 years $26.79 +104.2% $4.40 $2,206 +120.6%
5 years $29.14 +87.7% $7.22 $2,124 +112.4%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever TRST does next, these words stay.

TrustCo Bank Corp NY · TRST · Markdown · $55.73
Recorded 2026-10-23 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.